Cargando…
Introduction of Preventive Vaccination of Meningococcal Meningitis using MenAfriVac in Northern Uganda 2017
BACKGROUND: Major outbreaks of meningococcal meningitis Sero-type A are cyclic; occurring every 10 years, with over 75% of the outbreak occurring within age category of 1–29 years. The overall objective of the preventative campaign was to reduce morbidity and mortality caused by meningococcal mening...
Autor principal: | Ssewankambo, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631665/ http://dx.doi.org/10.1093/ofid/ofx163.520 |
Ejemplares similares
-
MenAfriVac as an Antitetanus Vaccine
por: Borrow, Ray, et al.
Publicado: (2015) -
Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
por: Karachaliou, Andromachi, et al.
Publicado: (2015) -
Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac(®) in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa
por: Viviani, Simonetta
Publicado: (2022) -
Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine
por: Bårnes, Guro K., et al.
Publicado: (2016) -
Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso
por: Ba, Absatou Ky, et al.
Publicado: (2014)